Back to All Events
Skip Intro Advisors CEO David Feldman will be speaking and Psychedelics and Regulatory Advisor Courtney Barnes will be attending.
Previous
Previous
January 25
CRISPR: Patent Disputes and Licensing Challenges
Next
Next
March 1